Sagittarius Life Science Corp. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sagittarius Life Science Corp. with three other
companies in this sector in Taiwan:
Genovate Biotechnology Co., Limited
sales of 408.27 million Taiwanese Dollars [US$13.66 million]
of which 93%
was Medicine Manufacturing),
Tien Liang Biotech Co Ltd
(515.46 million Taiwanese Dollars [US$17.25 million]
TSH Biopharm Corp Limited
(486.28 million Taiwanese Dollars [US$16.27 million]
Sagittarius Life Science Corp. reported sales of 462.82 million Taiwanese Dollars (US$15.49 million)
December of 2017.
decrease of 66.6%
versus 2016, when the company's sales were 1.38 billion Taiwanese Dollars.
Contributing to the drop in overall sales was the 68.4% decline
in Non-Toxic Sector, from 1.32 billion Taiwanese Dollars to 417.08 million Taiwanese Dollars.
There were also decreases in sales in
Other Department (down 30.5% to 45.74 million Taiwanese Dollars)